Global Antisense & RNAi Therapeutics Market Research Report 2022: Analysis of Oncology, Cardiovascular Diseases, Respiratory Disorders, Neurological Disorders, & Infectious Diseases
21 juin 2022 04h23 HE
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication" report has been added to ResearchAndMarkets.com's...
Global RNA Therapeutics Market Analysis Report 2022: Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas
20 juin 2022 08h03 HE
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Global RNA Therapeutics Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview...
Growth Opportunities in Predictive Genetic Testing, AI-enabled Drug Discovery, Circular RNA and Advanced Drug Delivery Market: Tapping into the Unexplored Biological Networks in Age-Related Diseases
17 juin 2022 05h48 HE
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Predictive Genetic Testing, AI-enabled Drug Discovery, Circular RNA, and Advanced Drug Delivery" report has been added to...
The Worldwide RNA Based Therapeutic Industry is Expected to Reach $11.4 Billion by 2027
24 mai 2022 06h58 HE
|
Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Global RNA Based Therapeutic Market By Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027" report...
Outlook on the RNA Based Therapeutic Global Market to 2030 - Multifactorial Disease Targeting Presents Opportunities
28 avr. 2022 06h43 HE
|
Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "RNA Based Therapeutic Market by Disease Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
Global RNAi Therapeutics Market Insights & Forecast Report 2022-2026: Rising Utilization in Oncology Pharmaceuticals & Progress in Collaborations and Associated Deals in RNAi Therapeutics
21 avr. 2022 04h43 HE
|
Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...
Global RNAi Therapeutics Market Report 2022-2026: Analysis by Molecule Type - Small Interference RNA (siRNA), and Micro RNA (miRNA)
08 avr. 2022 06h23 HE
|
Research and Markets
Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026"...
Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference
24 févr. 2022 08h47 HE
|
Oncotelic Therapeutics, Inc.
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is currently undergoing a phase 1b trial in combination...
mRNA Therapeutics and Vaccine Market Report 2022: Key Opinion Leaders Profiles and Recent Activity Snapshots
24 févr. 2022 04h28 HE
|
Research and Markets
Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics and Vaccines: Key Opinion Leaders" report has been added to ResearchAndMarkets.com's offering. Over the last two decades, medical...
Global RNA Stabilization & Delivery Technology Advances Market Report 2021: LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years
15 févr. 2022 05h43 HE
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Technological Advances in RNA Stabilization & Delivery" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a rapidly...